Literature DB >> 18587265

Cytosolic accumulation of gammaH2AX is associated with tropomyosin-related kinase A-induced cell death in U2OS cells.

Eun Joo Jung1, Choong Won Kim, Deok Ryong Kim.   

Abstract

Tropomyosin-related kinase A (TrkA) plays an important role in cell survival, differentiation, and apoptosis in various neuronal and nonneuronal cell types. Here we show that TrkA overexpression by the Tet-On system mimics NGF-mediated activation pathways in the absence of nerve growth factor (NGF) stimulation in U2OS cells. In addition, p53 upregulation upon DNA damage was inhibited by TrkA, and p21 was upregulated by TrkA in a p53-independent manner. TrkA overexpression caused cell death by interrupting cell cycle progression, and TrkA-induced cell death was diminished in the presence of its specific inhibitor GW441756. Interestingly, TrkA-mediated cell death was strongly related to gammaH2AX production and poly (ADP-ribose) polymerase cleavage in the absence of DNA damage inducer. In this study, we also reveal that gammaH2AX production by TrkA is blocked by TrkA kinase inhibitors K-252a and GW441756, and it is also significantly inhibited by JNK inhibitor SP600125. Moreover, reduction of cell viability by TrkA was strongly suppressed by SP600125 treatment, suggesting a critical role of JNK in TrkA-induced cell death. We also found that gammaH2AX and TrkA were colocalized in cytosol in the absence of DNA damage, and the nuclear localization of gammaH2AX induced by DNA damage was partly altered to cytosol by TrkA overexpression. Our results suggest that the abnormal cytosolic accumulation of gammaH2AX is implicated in TrkA-induced cell death in the absence of DNA damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18587265      PMCID: PMC2679291          DOI: 10.3858/emm.2008.40.3.276

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  31 in total

1.  Transfection-mediated cell synchronization: acceleration of G1-S phase transition by gamma irradiation.

Authors:  E J Jung; E K Flemington
Journal:  Biotechniques       Date:  2001-11       Impact factor: 1.993

2.  Cell cycle-dependent expression of phosphorylated histone H2AX: reduced expression in unirradiated but not X-irradiated G1-phase cells.

Authors:  Susan H MacPhail; Judit P Banáth; Ying Yu; Eric Chu; Peggy L Olive
Journal:  Radiat Res       Date:  2003-06       Impact factor: 2.841

Review 3.  H2AX: the histone guardian of the genome.

Authors:  Oscar Fernandez-Capetillo; Alicia Lee; Michel Nussenzweig; André Nussenzweig
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

4.  ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53.

Authors:  Damu Tang; Dongcheng Wu; Atsushi Hirao; Jill M Lahti; Lieqi Liu; Brie Mazza; Vincent J Kidd; Tak W Mak; Alistair J Ingram
Journal:  J Biol Chem       Date:  2002-01-30       Impact factor: 5.157

5.  Detection of protein-protein interactions by coimmunoprecipitation and dimerization.

Authors:  L J Ransone
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

6.  NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1.

Authors:  G Z Yan; E B Ziff
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

7.  Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses.

Authors:  R M Stephens; D M Loeb; T D Copeland; T Pawson; L A Greene; D R Kaplan
Journal:  Neuron       Date:  1994-03       Impact factor: 17.173

8.  TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.

Authors:  Antonella Tacconelli; Antonietta R Farina; Lucia Cappabianca; Giuseppina Desantis; Alessandra Tessitore; Antonella Vetuschi; Roberta Sferra; Nadia Rucci; Beatrice Argenti; Isabella Screpanti; Alberto Gulino; Andrew R Mackay
Journal:  Cancer Cell       Date:  2004-10       Impact factor: 31.743

Review 9.  DNA damage-induced activation of ATM and ATM-dependent signaling pathways.

Authors:  Ebba U Kurz; Susan P Lees-Miller
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

10.  Nerve growth factor-induced growth arrest and induction of p21Cip1/WAF1 in NIH-3T3 cells expressing TrkA.

Authors:  S J Decker
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

View more
  9 in total

1.  Transcription of the protein kinase C-delta gene is activated by JNK through c-Jun and ATF2 in response to the anticancer agent doxorubicin.

Authors:  Byong Wook Min; Chang Gun Kim; Jesang Ko; Yoongho Lim; Young Han Lee; Soon Young Shin
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

2.  Cross-talk between androgen receptor/filamin A and TrkA regulates neurite outgrowth in PC12 cells.

Authors:  Marzia Di Donato; Antonio Bilancio; Loredana D'Amato; Pamela Claudiani; Maria Antonietta Oliviero; Maria Vittoria Barone; Alberto Auricchio; Ettore Appella; Antimo Migliaccio; Ferdinando Auricchio; Gabriella Castoria
Journal:  Mol Biol Cell       Date:  2015-06-10       Impact factor: 4.138

3.  Induction of neurite outgrowth in PC12 cells treated with temperature-controlled repeated thermal stimulation.

Authors:  Tada-aki Kudo; Hiroyasu Kanetaka; Kentaro Mochizuki; Kanako Tominami; Shoko Nunome; Genji Abe; Hiroyuki Kosukegawa; Toshihiko Abe; Hitoshi Mori; Kazumi Mori; Toshiyuki Takagi; Shin-ichi Izumi
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

4.  Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells.

Authors:  Aditi A Bapat; Ruben M Munoz; Daniel D Von Hoff; Haiyong Han
Journal:  PLoS One       Date:  2016-10-28       Impact factor: 3.240

5.  Cross-talk between androgen receptor and nerve growth factor receptor in prostate cancer cells: implications for a new therapeutic approach.

Authors:  Marzia Di Donato; Gustavo Cernera; Ferdinando Auricchio; Antimo Migliaccio; Gabriella Castoria
Journal:  Cell Death Discov       Date:  2018-01-31

6.  Effectiveness of a Fractionated Therapy Scheme in Tumor Treating Fields Therapy.

Authors:  Yunhui Jo; Jiwon Sung; Hyesun Jeong; Sunghoi Hong; Youn Kyoung Jeong; Eun Ho Kim; Myonggeun Yoon
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

7.  Proteomic analysis of novel targets associated with TrkA-mediated tyrosine phosphorylation signaling pathways in SK-N-MC neuroblastoma cells.

Authors:  Eun Joo Jung; Sang-Yeul Lee; Choong Won Kim
Journal:  Proteomics       Date:  2013-01       Impact factor: 3.984

8.  Low-density Lipoprotein Receptor-related Proteins in a Novel Mechanism of Axon Guidance and Peripheral Nerve Regeneration.

Authors:  Lila M Landowski; Macarena Pavez; Lachlan S Brown; Robert Gasperini; Bruce V Taylor; Adrian K West; Lisa Foa
Journal:  J Biol Chem       Date:  2015-11-23       Impact factor: 5.157

9.  LMTK3 confers chemo-resistance in breast cancer.

Authors:  Justin Stebbing; Kalpit Shah; Lei Cheng Lit; Teresa Gagliano; Angeliki Ditsiou; Tingting Wang; Franz Wendler; Thomas Simon; Krisztina Sára Szabó; Timothy O'Hanlon; Michael Dean; April Camilla Roslani; Swee Hung Cheah; Soo-Chin Lee; Georgios Giamas
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.